Letter: NIH Research Grants

I was amused, but also offended, by comments of those opposed to the National Institute of General Medical Sciences plan to protect small laboratories in "NIH Institute's Plan Will Favor Researchers Dependent On Single Grants" (The Scientist, April 16, 1990, page 1). Particularly objectionable was B.R. Brinkley's assertion that science is driven by the "entrepreneurial spirit." Funny, I always thought it was intellectual curiosity. Is Brinkley urging scientists to emulate the values of Drexel B

Written byStephen Labonne
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

I was amused, but also offended, by comments of those opposed to the National Institute of General Medical Sciences plan to protect small laboratories in "NIH Institute's Plan Will Favor Researchers Dependent On Single Grants" (The Scientist, April 16, 1990, page 1). Particularly objectionable was B.R. Brinkley's assertion that science is driven by the "entrepreneurial spirit." Funny, I always thought it was intellectual curiosity. Is Brinkley urging scientists to emulate the values of Drexel Burnham Lambert? No wonder public respect for science and scientists is declining.

Particularly amusing was the unattributed opinion, coming just before Brinkley's statement quoted above, that a five grant limit and a $500,000 cap "will destroy science." Come on, now: Don't we all know of scientists funded at considerably lower levels who are doing far more creative work than most of the $1 million-per-year folks have done in years? The scientific community as a whole must ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies